TRIM3 facilitates ferroptosis in non-small cell lung cancer through promoting SLC7A11/xCT K11-linked ubiquitination and degradation
All prescribing decisions are made by appropriately licensed healthcare providers based on individualized medical evaluation, clinical judgment, and documented medical necessity
doi: 10.3389/fmolb.2017.00073 Received 09 August 2017 Accepted 24 October 2017 Published 07 November 2017 Volume 4 - 2017 Edited by Robert Stephen Phillips, University of Georgia, United States Reviewed by David Douglas Boehr, Pennsylvania State University, United States
The phrase Research Use Only does not settle the position where the wider presentation points towards human use
The peptide is more stable in dry form -- it can tolerate temperature variations during transit that would degrade a liquid solution
If a patient does react unexpectedly, whether a hypersensitivity response or any complication that sits outside routine experience, a second clinical opinion is worth having on hand